Abstract
BSp6S and BSp73AS are two rat tumors which grow locally after intra-footpad (ifp) application. BSp73ASML and BSp6AS are variants, which metastasize via the lymphatics. Both variants have lost adherence properties, as shown byin vitro culture on plastic surfaces, suggesting that loss of adherence may be accompanied by increased metastasizing capacity. However, after growth of BSp6S and BSp73ASin vitro on poly(2-hydroxyethylmethacrylate) (polyHEMA)-coated plates, which resulted in loss of adherence and spreading, and subsequent intravenous (iv) or ifp injection of non-adherent tumor cells into syngeneic rats, metastasizing capacity was not increased. It is concluded that loss of adherence may facilitate metastatic spread, but certainly is not sufficient for initiation.
Similar content being viewed by others
Abbreviations
- BSS:
-
Hank's balanced salt solution
- RPMI-s:
-
RPMI 1640, supplemented with antibiotics,l-glutamine and 10% fetal calf serum
- LN:
-
lymph nodes
- SC:
-
spleen cells
- Mo:
-
peritoneal macrophages
- iv:
-
intravenous
- ifp:
-
intra-footpad
- sc:
-
subcutaneous
- ip:
-
intraperitoneal
- PH/polyHEMA:
-
poly(2-hydroxyethylmethacrylate)
- IFN:
-
interferon-gamma
- CP:
-
Corynebacterium parvum
References
Ben-Ze'ev, A., 1985, The cytoskeleton in cancer cells.Biochimica Biophysica Acta,780, 197–212.
Ben-Ze'ev, A., Zöller, M., andRaz, A., 1986, Differential expression of intermediate filament proteins in metastatic and nonmetastatic variants of the BSp73 tumor.Cancer Research,46, 785–790.
Ben-Ze'ev, A., andRaz, A., 1981, Multinucleation and inhibition of cytokinesis in suspended cells: reversal upon reattachment to a substrate.Cell,26, 107–115.
Brodt, P., Feldman, M., andSegal, S., 1983, Differences in the metastatic potential of two sublines of tumor 3LL selected for resistance to natural NK-like effector cells.Cancer Immunology and Immunotherapy,16, 109–113.
Carlow, D. A., Kerbel, R. S., Feltis, J. T., andElliott, B. E., 1985, Enhanced expression of class I major histocompatibility complex gene (DK) products on immunogenic variants of a spontaneous murine carcinoma.Journal of the National Cancer Institute,75, 291–301.
Gorelik, E., Feldman, M., andSegal, S., 1982, Selection of 3LL tumor sublines resistant to natural effector cells concomitantly selected for increased metastatic potency.Cancer Immunology and Immunotherapy,12, 105–109.
Heppner, G. H., andMiller, B. E., 1983, Tumor heterogeneity: biological implications and therapeutic consequences.Cancer Metastasis Reviews,2, 5–33.
Karre, K., Ljunggren, H. G., Piontek, G., andKiessling, R., 1986, Selective rejection of H-2 deficient lymphoma variants suggests alternative immune defense strategy.Nature (London),319, 675–678.
Keller, R., 1978, Abrogation of antitumor effects ofCorynebacterium parvum and BCG by antimacrophage agents.Journal of the National Cancer Institute,59, 1751–1753.
Klein, P. A., Xiang, J., andKimura, A. K., 1984, Melanoma cells growing in aggregates on a non-adhesive poly(HEMA) substrate exhibit polykaryocytosis but do not develop an increased metastatic capability.Clinical and Experimental Metastasis,2, 287–295.
Kurnick, J. T., Oestberg, L., Stegagno, M., Kimura, A. J., Oern, A., andSjoeberg, O., 1979, A rapid method for separation of functional lymphoid cell populations of human and animal origin on PVC-silica (Percoll) density gradients.Scandinavian Journal of Immunology,10, 563–572.
Liotta, L. A., 1984, Tumor invasion and metastases: Role of the basement membrane.American Journal of Pathology,117, 339–348.
Mareel, M. M., andDeMets, M., 1984, Effect of microtubule inhibitors on invasion and on related activities of tumor cells.International Reviews in Cytology,90, 125–168.
Matzku, S., Komitowski, D., Mildenberger, M., andZöller, M., 1983, Characterization of BSp73, a spontaneous rat tumor and itsin vivo selected variants showing different metastasizing capacities.Invasion and Metastasis,3, 109–123.
Matzku, S., 1984, Natural cytotoxicity in lymphatic metastasis. II.In vivo studies with BSp73 variants differing in metastatic capacity.Cancer Immunology Immunotherapy,17, 106–111.
Matzku, S., Oberneder, H. P., Keller, R., andZöller, M., 1984, Natural cytotoxicity in lymphatic metastasis. I.In vitro studies using the rat tumor BSp73 and its variants.Cancer Immunology and Immunotherapy,17, 100–105.
McCarthy, J. B., Basara, M. L., Palm, S. L., Sas, D. F., andFurcht, L. T., 1985, The role of cell adhesion proteins-laminin and fibronectin-in the movement of malignant and metastatic cells.Cancer and Metastasis Reviews,4, 125–152.
Nicolson, G. L., 1984, Cell surface molecules and tumor metastasis.Experimental Cell Research,150, 3–22.
Ojo, E., Haller, O., andWigzell, H., 1978,Corynebacterium parvum-induced peritoneal exudate cells with rapid cytolytic activity against tumor cells are nonphagocytic cells with characteristics of natural killer cells.Scandinavian Journal of Immunology,8, 215–222.
Poste, G., Doll, J., Hart, I. R., andFidler, I. J., 1980,In vitro selection of murine B16 melanoma variants with enhanced tissue invasive properties.Cancer Research,40, 1636–1642.
Raz, A., Zöller, M., andBen-Ze'ev, A., 1986, Cell configuration and adhesive properties of metastasizing and non-metastasizing BSp73 rat adenocarcinoma cells.Experimental Cell Research,162, 127–141.
Raz, A., andBen-Ze'ev, A., 1983, Modulation of the metastatic capability in B16 melanoma by cell shape.Science,221, 1307–1310.
Raz, A., andBen-Ze'ev, A., 1982, Growth control and cell spreading: Differential response in preneoplastic and in metastatic cell variants.International Journal of Cancer,29, 711–715.
Roos, E., 1984, Cellular adhesion, invasion and scmetastasis.Biochimica Biophysica Ada,738, 263–284.
Sarzotti, M., Baron, S., Tyring, S. K., andKlimpel, G. R., 1986, Interferon-mediated protection of Bl 6 melanoma cells from cytotoxicity by activated macrophages.Cellular Immunology,100, 280–287.
Stackpole, C. W., 1981, Distinct lung-colonizing and lung metastasizing cell populations in B16 mouse melanoma.Nature (London),289, 798–800.
Starkley, J. R., Davis, W. C., andTalmadge, J. E., 1982, Immunoselection of tumor variants resistant to antibody-mediated cytotoxicity.Cancer Immunology and Immuno-therapy,14, 124–131.
Sugarbaker, E. V., 1981, Patterns of metastasis in human malignancies.Cancer Biological Reviews,2, 235–278.
Taniguchi, K., Karre, K., andKlein, G., 1985, Lung colonization and metastasis by disseminated B16 melanoma cells: H-2 associated control at the level of the host and the tumor cell.International Journal of Cancer,36, 503–510.
Turner, G. A., 1982, Surface properties of the metastatic cell.Invasion and Metastasis,2, 197–212.
Wallich, R., Bulbuc, N., Hämmerling, G. J., Katzav, S., Segal, S., andFeldman, M., 1985, Abrogation of metastatic properties of tumor cells by de novo expression of H2-K antigens following H-2 gene transfection.Nature (London),315, 301–305.
Welsh, R. M., Karre, K., Hannson, M., Kunkel, L. A., andKiessling, R. W., 1981, Interferon-mediated protection of normal and tumor target cells against lysis by mouse natural killer cells.Journal of Immunology,126, 219–225.
Zöller, M., 1986, Acquired resistance towards immune defense during metastatic progression represents a secondary phenomenon.International Journal of Cancer,37, 115–122.
Zöller, M., Matzku, S., andGoerttler, K. L., 1978, High incidence of spontaneous, transplantable tumors in BDX rats.British Journal of Cancer,37, 61–69.
Zöller, M., andWigzell, H., 1982, Naturally occurring inhibitory cells for natural killer (NK) cell activity. I. Organ distribution.Cellular Immunology,74, 14–26.
Zöller, M., andMatzku, S., 1982, Rat macrophages inhibit natural killer (NK) cell activity against adherent growing target cells.Immunobiology,163, 497–510.
Zöller, M., 1988, IFN-treatment of B16-F1 versus B16-F10: relative importance of non-adaptive and T-cell-mediated immune defense in metastatic spread.Clinical and Experimental Metastasis,6, 411–429.
Zöller, M., Strubel, A., Hämmerling, G., Andrighetto, G., Raz, A., andBen-Ze'ev, A., 1988, Interferon-gamma treatment of B16 melanoma cells: opposing effects for nonadaptive and adaptive immune defense and its reflection by metastatic spread.International Journal of Cancer,41, 256–266.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Zöller, M., Matzku, S. Changes in adhesive properties of tumor cells do not necessarily influence metastasizing capacity. Clin Exp Metast 7, 227–242 (1989). https://doi.org/10.1007/BF01787026
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01787026